New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy
Open Access
- 2 December 2020
- journal article
- case report
- Published by Wiley in Clinical Case Reports
- Vol. 9 (1) , 61-66
Abstract
Association of immunotherapy and/or chemotherapy and/or targeted therapy, in sequence or as single therapies, may induce osteonecrosis of the jaw. Multidisciplinary team management of these patients should be provided.Keywords
This publication has 24 references indexed in Scilit:
- Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patientsJournal of Cranio-Maxillofacial Surgery, 2016
- Osteonecrosis of the jaw a new complication related to IpilimumabOral Oncology, 2015
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014
- Osteonecrosis of the jaw related to everolimus: a case reportBritish Journal of Oral and Maxillofacial Surgery, 2013
- The relationship of denosumab pharmacology and osteonecrosis of the jawsOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
- Sunitinib related osteonecrosis of jaw: a case reportOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
- Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implicationsOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Osteonecrosis of the Jaw Related to BevacizumabJournal of Clinical Oncology, 2008
- Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone MetastasesJournal of Clinical Oncology, 2007